达唑氧苯在静息及心房起搏时的血流动力学和代谢效应。
Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.
作者信息
Kiff P S, Bergman G, Atkinson L, Jewitt D E, Westwick J, Kakkar V V
出版信息
Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):73S-77S. doi: 10.1111/j.1365-2125.1983.tb02112.x.
Abstract
1 Thromboxane B2 (TXB2) levels were measured in three sites (coronary sinus, pulmonary artery, and femoral artery) at rest and during atrial pacing in 11 patients with stable angina pectoris. 2 There was a highly significant increase in arterial TXB2 on pacing (by up to 820 pg/ml) but there was no change in the thromboxane levels at the other two sites. 3 Dazoxiben 200 mg orally abolished the increase in arterial TXB2, but had no effect on systemic, pulmonary or coronary haemodynamics, no effect on myocardial metabolism and a variable effect on atrial pacing time to angina.
摘要
- 在11例稳定型心绞痛患者静息状态及心房起搏期间，于三个部位（冠状窦、肺动脉和股动脉）测定了血栓素B2（TXB2）水平。2. 起搏时动脉TXB2显著升高（最高达820 pg/ml），但其他两个部位的血栓素水平无变化。3. 口服200 mg达唑氧苯可消除动脉TXB2的升高，但对全身、肺或冠状动脉血流动力学无影响，对心肌代谢无影响，对心房起搏诱发心绞痛的时间影响不一。
相似文献
1
Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.达唑氧苯在静息及心房起搏时的血流动力学和代谢效应。
Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):73S-77S. doi: 10.1111/j.1365-2125.1983.tb02112.x.
2
Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease.大唑氧苯对冠心病经心腔血栓素水平及血流动力学的影响。
Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):79S-82S. doi: 10.1111/j.1365-2125.1983.tb02113.x.
3
Selective inhibition of thromboxane synthesis during experimental endotoxemia in the goat: effects on pulmonary haemodynamics and lung lymph flow.山羊实验性内毒素血症期间血栓素合成的选择性抑制：对肺血流动力学和肺淋巴流量的影响。
Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):123S-126S. doi: 10.1111/j.1365-2125.1983.tb02122.x.
4
Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test.特异性血栓素合成酶抑制对运动试验诱发的稳定型心绞痛中血栓素和前列腺素合成的影响。
Thromb Res. 1985 Jan 15;37(2):259-66. doi: 10.1016/0049-3848(85)90014-3.
5
Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease.选择性血栓素合成酶抑制剂达唑氧苯和乙酰水杨酸对冠心病患者心肌缺血的影响。
Am J Cardiol. 1984 May 1;53(9):1255-8. doi: 10.1016/0002-9149(84)90074-2.
6
Effect of atrial pacing on intracoronary thromboxane production in coronary artery disease.心房起搏对冠心病患者冠状动脉内血栓素生成的影响。
J Am Coll Cardiol. 1983 May;1(5):1194-200. doi: 10.1016/s0735-1097(83)80129-6.
7
Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.心绞痛患者心肌缺血期间血栓素生成及补体激活的评估。
Circulation. 1991 Nov;84(5):2054-62. doi: 10.1161/01.cir.84.5.2054.
8
Effects of dazoxiben on exercise performance in chronic stable angina.达唑氧苯对慢性稳定型心绞痛运动能力的影响。
Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):83S-86S. doi: 10.1111/j.1365-2125.1983.tb02114.x.
9
10
Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia.高剂量阿司匹林对起搏诱发心肌缺血时冠状动脉血流动力学的影响。
J Am Coll Cardiol. 1985 Feb;5(2 Pt 1):210-5. doi: 10.1016/s0735-1097(85)80039-5.
引用本文的文献
1
Effect of the specific thromboxane receptor blocking drug AH23848 in patients with angina pectoris.特异性血栓素受体阻断药物AH23848对心绞痛患者的疗效。
Br Heart J. 1986 Dec;56(6):509-17. doi: 10.1136/hrt.56.6.509.
本文引用的文献
1
Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.起搏诱导型心绞痛期间的血栓素释放：对冠状动脉血管系统可能的血管收缩作用影响。
Circulation. 1980 Jun;61(6):1165-71. doi: 10.1161/01.cir.61.6.1165.
2
Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.典型和变异型心绞痛患者血栓素B2水平升高。
Circulation. 1981 Dec;64(6):1107-15. doi: 10.1161/01.cir.64.6.1107.
3
Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease.吲哚美辛对冠心病患者的冠状动脉收缩作用。
N Engl J Med. 1981 Nov 12;305(20):1171-5. doi: 10.1056/NEJM198111123052002.
4
Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris.奥昔非君（L-羟基苯甘氨酸）后心肌碳水化合物利用增强对心绞痛的有益作用。
Eur Heart J. 1980 Aug;1(4):247-53. doi: 10.1093/oxfordjournals.eurheartj.a061126.
5
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.血管紧张性心绞痛中的血栓素A2：直接测量和抑制剂试验的证据
N Engl J Med. 1981 Apr 23;304(17):998-1003. doi: 10.1056/NEJM198104233041703.
6
Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.缺血性心脏病患者体内前列腺素和血栓素释放至冠状动脉循环中。
N Engl J Med. 1981 Mar 19;304(12):685-91. doi: 10.1056/NEJM198103193041201.
7
Circulating platelet products in unstable angina pectoris.不稳定型心绞痛中的循环血小板产物
Circulation. 1981 Feb;63(2):300-6. doi: 10.1161/01.cir.63.2.300.
8
Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease.前列环素：对冠心病患者的血流动力学及代谢影响
Lancet. 1981 Mar 14;1(8220 Pt 1):569-72. doi: 10.1016/s0140-6736(81)92028-6.
9
Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm.自发性冠状动脉痉挛患者外周血和冠状窦血中的血小板聚集体
Lancet. 1980 Oct 18;2(8199):829-31. doi: 10.1016/s0140-6736(80)90175-0.
Zotero 插件